EAGLE PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic in USD/shares from 2013 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2013 to 2022.
  • Eagle Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2023 was 0.39 USD/shares.
  • Eagle Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2023 was 0.86 USD/shares, a 52.7% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was 2.76 USD/shares.
  • Eagle Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -0.66 USD/shares, a 174% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2020 was 0.89 USD/shares, a 14.4% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.76 +$3.42 Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 -$1 -$2 -174% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $0.89 $0 -14.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $1.04 -$1 -51.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $2.16 -$1 -37.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $3.44 -$2 -34.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $5.24 +$5.07 +2982% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $0.17 +$2.14 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$2 +$1.28 +39.4% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 -$3 Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.